Ma, Wen-Ya
Universidad de Guadalajara
3 papers on CoChatORCID 0000-0003-3773-5716
Most cited papers
- Verified
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 3,163
- Verified
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 638
- Verified
Enhanced self-efficacy and behavioral changes among patients with diabetes: cloud-based mobile health platform and mobile app service
Chao, D. Y., Lin, T. M., & Ma, W.-Y. (2019) · JMIR Diabetes
Mobile Health and mHealth ApplicationsDiabetes Management and Education
Cited by 82
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free